Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Clinical trial NCT07432594 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07432594
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-05-30
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.